Close
Updated:

Defective drug: Amiodarone, a widely use arrhythmia drug may increase cancer risk

A new study published in CANCER, a peer-reviewed journal of the American Cancer Society, shows that Amioradone, marketed since 1985 and used for arrhythmia or irregular heartbeats may increase cancer especially for patient using large doses.

Contact Us